Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

43 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Building A Future-Proof IP Strategy For AI In Medtech

    The healthtech industry is witnessing fierce competition as companies develop AI-powered tools for clinical decision support, robotic surgery, medical imaging, and drug discovery.
    GlobalIntellectual Property
    Greenberg Traurig
    Greenberg Traurig
  • Podcast

    Episode 16: Guy Goldman Of Olive Diagnostics (Podcast)

    Guy Goldman is the Founder and CEO of Olive Diagnostics.
    IsraelFood, Drugs, Healthcare, Life Sciences
    JMB Davis Ben-David
    JMB Davis Ben-David
Podcast

Israeli Technology Founders Speak - Tanya Attias Of MedInt (Podcast)

Tanya Attias is the founder and CEO of MedInt, a medical technology startup that is using AI and human experts to create a database to help doctors quickly make decisions based on the latest medical information.
IsraelTechnology
JMB Davis Ben-David
JMB Davis Ben-David
  • Article

    Healthcare And Life Sciences Legal Update | January 2019

    The Israeli Ministry of Health ("MOH") has since 2016 been implementing a precedential and revolutionary reform regarding medical cannabis, which regulates all phases of the medical cannabis process,
    IsraelFood, Drugs, Healthcare, Life Sciences
    Gross, Kleinhendler, Hodak, Halevy, Greenberg & Co.
    Gross, Kleinhendler, Hodak, Halevy, Greenberg & Co.
  • Article

    Israeli MoH To Disclose Personal Data Of Unvaccinated Individuals To Local Authorities

    The Israeli legislature (the "Knesset") passed an amendment to the Public Health Ordinance
    IsraelPrivacy
    Pearl Cohen Zedek Latzer Baratz
    Pearl Cohen Zedek Latzer Baratz
  • Article

    Israel Discloses Its Agreement With Pfizer For De-identified COVID-19 Vaccine-related Health Data

    The Israeli Ministry of Health ("MoH") disclosed its agreement with pharmaceutical giant Pfizer.
    IsraelCoronavirus (COVID-19)
    Pearl Cohen Zedek Latzer Baratz
    Pearl Cohen Zedek Latzer Baratz
  • Podcast

    Episode 18: Keren Leshem Of Ocon Healthcare (Podcast)

    Episode 18: Keren Leshem Of Ocon Healthcare (Podcast)
    IsraelFood, Drugs, Healthcare, Life Sciences
    JMB Davis Ben-David
    JMB Davis Ben-David
  • Article

    Healthcare And Life Sciences Legal Update | December 2018

    The Israeli Parliament approved on December 25, 2018, an amendment to the Dangerous Drugs Ordinance – 1973, which, amongst others, regulates medical cannabis (the "Amendment").
    IsraelFood, Drugs, Healthcare, Life Sciences
    Gross, Kleinhendler, Hodak, Halevy, Greenberg & Co.
    Gross, Kleinhendler, Hodak, Halevy, Greenberg & Co.
  • Article

    Inventor Tribute: Professor Raphael (Raphi) Mechoulam

    Israeli cannabis researcher Professor Raphael Mechoulam, passed away last week at the age of 92.
    IsraelCannabis & Hemp
    JMB Davis Ben-David
    JMB Davis Ben-David
  • Article

    Digital Health In The Age Of Corona

    The Corona pandemic demonstrates the important role of digital health in the medical world. In most western countries, Corona health policy is based on epidemiological "big data" prediction.
    IsraelFood, Drugs, Healthcare, Life Sciences
    Yigal Arnon & Co
    Yigal Arnon & Co
  • Article

    Update Regarding The Ministry Of Health Guidelines For Handling The Corona Virus

    Following our previous client updates, we bring to your attention two most recent amendments to the Public Health Order (New Corona Virus) (Home Quarantine) (Temporary Order, 2020), published on March 5, 2020, ...
    IsraelFood, Drugs, Healthcare, Life Sciences
    Herzog Fox & Neeman
    Herzog Fox & Neeman
  • Article

    Post No. 1: Digital Health Is A Game Changer

    Wake up to a new morning. Routine day. A wrist bracelet informs the refrigerator about the breakfast menu, in line with a new diet you decided to try.
    IsraelFood, Drugs, Healthcare, Life Sciences
    Yigal Arnon & Co
    Yigal Arnon & Co
  • Article

    Covid-19 National Repository For Research

    In the struggle against Covid-19, medical data constitutes an essential tool in finding new treatments, developing vaccines, mitigating the spread of the virus, and assisting policy makers to make...
    IsraelCoronavirus (COVID-19)
    Yigal Arnon & Co
    Yigal Arnon & Co
  • Article

    MOH's Procedure On The Use Of Digital Means In Informed Consent

    In the struggle against Covid-19, medical research constitutes an essential tool in finding new treatments and developing vaccines.
    IsraelFood, Drugs, Healthcare, Life Sciences
    Yigal Arnon & Co
    Yigal Arnon & Co
  • Article

    Coronavirus And Commercial Contracts: Legal Implications And Practical Considerations

    The outbreak of coronavirus is widely being reported as having an impact on global manufacturing, shipping and cross-border supply chains as well as on local commercial dealings, thereby undermining many aspects of trade and commerce.
    IsraelCorporate/Commercial Law
    Herzog Fox & Neeman
    Herzog Fox & Neeman
  • Article

    Post No. 4 – A Stethoscope Of One's Own - Femtech (Feminine Technology)

    Did you know that the gynecological speculum was invented in 1845, under dubious circumstances? If you don't know what a speculum is, you're probably, well, a man.
    IsraelFood, Drugs, Healthcare, Life Sciences
    Yigal Arnon & Co
    Yigal Arnon & Co
  • Article

    Post No. 6 - Use Of Medical Data

    Medical information accumulated during therapeutic treatment over the years can have a tremendous impact on medical progress and treatment. Medical companies are using these data to develop
    IsraelPrivacy
    Yigal Arnon & Co
    Yigal Arnon & Co
  • Article

    Digital Health 101 - Use Of Medical Data

    Medical information accumulated during therapeutic treatment over the years can have a tremendous impact on medical progress and treatment.
    IsraelFood, Drugs, Healthcare, Life Sciences
    Yigal Arnon & Co
    Yigal Arnon & Co
  • Article

    GDPR And Digital Health

    The GDPR identifies three specific examples where a DPIA would be required.
    European UnionPrivacy
    Epstein Rosenblum Maoz
    Epstein Rosenblum Maoz
  • Article

    Allergan v. B4U—Trademark Infringement

    In a decision of the Israeli District Court dated January 12, 2005, in the framework of provisional proceedings in the matter of C.A. 2332/04, MCA 20294/04 <I>Allergan, Inc. et al.,</I> <I>v. B4U Ltd. et al. </I>(not yet published), it was held, <I>inter alia, </I>that respondents’ use of the marks "BOTO EFFECT" and "BOTORELAX" infringe Allergan Inc.’s well-known trademark "BOTOX".
    IsraelCorporate/Commercial Law
    S Horowitz & Co
    S Horowitz & Co
  • Showing 1–20 of 43 results

    Next
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics